{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:44:10Z","timestamp":1792608250849,"version":"4.5.0"},"publisher-location":"Chichester, UK","reference-count":318,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000307","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T16:46:21Z","timestamp":1069346781000},"source":"Crossref","is-referenced-by-count":9,"title":["Depot fluphenazine decanoate and enanthate for schizophrenia"],"prefix":"10.1002","author":[{"given":"Anthony","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive E","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Eisenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema N","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rathbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,19]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD000307-BIB1|cit1","first-page":"181","article-title":"Fluphenazine decanoate trial in chronic inpatient schizophrenics failing to absorb oral chlorpromazine","volume":"34","author":"Adamson","year":"1973","journal-title":"Diseases of the Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB2|cit2","first-page":"897","article-title":"Long term double-blind evaluation of pipotiazine palmitate and fluphenazine decanoate","volume":"27","author":"Albert","year":"1980","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000307-BIB3|cit3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00431773","article-title":"Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients","volume":"87","author":"Altamura","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB4|cit4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpsyc.1988.01800330046005","article-title":"Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing skills","volume":"45","author":"Asarnow","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB5|cit5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00583530","article-title":"Use of the social behaviour assessment schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine","volume":"18","author":"Barnes","year":"1983","journal-title":"Social Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB6|cit6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/ajp.130.1.13","article-title":"Depot phenothiazine treatment in acute psychosis: A sequential comparative clinical study","volume":"130","author":"Chien","year":"1973","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB7|cit7","first-page":"148","article-title":"A double-blind controlled study of pipothiazine palmitate in the maintenane treatment of schizophrenic outpatients","volume":"Feb-Mar","author":"Chouinard","year":"1978","journal-title":"The Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB8|cit8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1176\/ajp.139.3.312","article-title":"Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: Extrapyramidal symptoms and therapeutic effect","volume":"139","author":"Chouinard","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB10|cit9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-198908000-00003","article-title":"A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia","volume":"9","author":"Chouinard","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB9|cit10","first-page":"108","article-title":"A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia","volume":"20","author":"Chouinard","year":"1984","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB11|cit11","first-page":"41","article-title":"Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanaote","volume":"Suppl1","author":"Cookson","year":"1986","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB12|cit12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.124.4.385","article-title":"Controlled trial of depot fluphenazine in out-patient schizophrenics","volume":"124","author":"Crawford","year":"1974","journal-title":"British Journal of Psychiatry"},{"issue":"776","key":"10.1002\/14651858.CD000307-BIB13|cit13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(72)91943-5","article-title":"Double-blind trial of fluphenazine decanoate","volume":"2","author":"Curry","year":"1972","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000307-BIB14|cit14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0447.1978.tb06879.x","article-title":"How schizophrenic patients change during 3 years' treatment with depot neuroleptics","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatria Scandanavia"},{"key":"10.1002\/14651858.CD000307-BIB15|cit15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0447.1978.tb06878.x","article-title":"Three years' maintenance neuroleptic treatment in schizophrenia - before and beyond","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"suppl 241","key":"10.1002\/14651858.CD000307-BIB16|cit16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0447.1973.tb07048.x","article-title":"A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes","volume":"241","author":"Dencker","year":"1973","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB17|cit17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0010-440X(76)90012-2","article-title":"Comparison of depot fluphenazines: Duration of action and incidence of side effects","volume":"17","author":"Donlon","year":"1976","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB18|cit18","first-page":"374","article-title":"Double blind trial of fluphenazine decanoate against placebo in ambulant maintenance treatment of chronic schizophrenics","volume":"14","author":"Dotti","year":"1979","journal-title":"Rivista di Psichiatria"},{"key":"10.1002\/14651858.CD000307-BIB19|cit19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033291700014318","article-title":"The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs fluphenazine","volume":"8","author":"Fallon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000307-BIB20|cit20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0033291700006632","article-title":"A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia","volume":"8","author":"Falloon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000307-BIB21|cit21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0364-7722(79)90050-X","article-title":"Medical-social evaluation of the long term pharmacotherapy of schizophrenia","volume":"3","author":"Shepherd","year":"1979","journal-title":"Progress Neuro-Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB22|cit22","first-page":"299","article-title":"Double blind controlled trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenia","volume":"16","author":"Feng","year":"1990","journal-title":"Chinese Journal of Nervous and Mental Disorders"},{"key":"10.1002\/14651858.CD000307-BIB23|cit23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1600-0447.1978.tb06912.x","article-title":"Double blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics","volume":"57","author":"Frangos","year":"1978","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archpsyc.1978.01770340019001","article-title":"Drug and family therapy in the aftercare of acute schizophrenics","volume":"35","author":"Goldstein MJ Rodnick","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB25|cit25","first-page":"209","article-title":"The interaction between depot-phenothiazines and the social and clinical manifestations of behaviour in patients with stabilised chronic schizophrenia","volume-title":"On the origin of schizophrenic psychoses","author":"Hirsch","year":"1975"},{"key":"10.1002\/14651858.CD000307-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/archpsyc.1979.01780120013001","article-title":"Fluphenazine and social therapy in the aftercare of schizophrenic patients","volume":"36","author":"Hogarty","year":"1979","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB27|cit27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archpsyc.1988.01800330021002","article-title":"Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia","volume":"45","author":"Hogarty","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB28|cit28","series-title":"11th Congress of The European College of Neuropsychopharmacology; 1998 Oct 3 - Nov 4; Paris, France","article-title":"Haloperidol decanoate and fluphenazine decanoate for schizophrenia: a comparative naturalistic medium term study of efficacy and tolerability","author":"Hranov","year":"1998"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB29|cit29","first-page":"585","article-title":"A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients","volume":"18","author":"Jain","year":"1975","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB30|cit30","first-page":"69","article-title":"Double blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia","volume":"1","author":"Javed","year":"1991","journal-title":"The Pakistan Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB31|cit31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bmj.301.6756.837","article-title":"Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years","volume":"301","author":"Jolley","year":"1990","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB33|cit32","first-page":"20","article-title":"Low -Dose Neuroleptics in Outpatient Schizophrenics","volume":"18","author":"Kane","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB32|cit33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1983.01790070083010","article-title":"Low-dose neuroleptic treatment of outpatient schizophrenics","volume":"40","author":"Kane","year":"1983","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB34|cit34","first-page":"15","article-title":"A double blind comparative study on the efficacy and safety of fluphenazine decanoate (SQ10, 733) and oral haloperidol in the treatment of schizophrenic patients","volume":"19","author":"Kaneno","year":"1991","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"key":"10.1002\/14651858.CD000307-BIB35|cit35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000468286","article-title":"Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia","volume":"12","author":"Kelly","year":"1977","journal-title":"International Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB36|cit36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00402099","article-title":"EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis","volume":"20","author":"Keskiner","year":"1971","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000307-BIB37|cit37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2007-1017373","article-title":"Double-blind comparison of haloperidol and fluphenazine decanoate effectiveness, side effects, dosage and serum levels during a six months treatment for relapse prevention","volume":"18","author":"Kissling","year":"1985","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB38|cit38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00332747.1988.11024375","article-title":"Family attitudes and patient social adjustment in a longitudinal study of outpatient schizophrenics receiving low-dose neuroleptics: the family's view","volume":"51","author":"Kreisman","year":"1988","journal-title":"Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB39|cit39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00408331","article-title":"A comparative study of two long acting phenothiazine preparations, fluphenazine enanthate and fluphenazine decanoate","volume":"9","author":"Kurland","year":"1966","journal-title":"Psychopharmacologia (Berl)"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB40|cit40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2007-1019621","article-title":"Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms","volume":"13","author":"Lehmann","year":"1980","journal-title":"Pharmakopsychiatrie und Neuropsychopharmakologie"},{"key":"10.1002\/14651858.CD000307-BIB41|cit41","first-page":"536","article-title":"A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia","volume":"30","author":"Leong","year":"1989","journal-title":"Singapore Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB42|cit42","first-page":"695","article-title":"Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol","volume":"20","author":"Levenson","year":"1976","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000307-BIB43|cit43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08039489009096549","article-title":"Community-based rehabilitation of schizophrenia","volume":"44","author":"Lundin","year":"1990","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB44|cit44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08039489209103313","article-title":"Community-based rehabilitation of schizophrenia: corrected version","volume":"46","author":"Lundin","year":"1992","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000307-BIB45|cit45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000117652","article-title":"Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia","volume":"4","author":"MacCrimmon","year":"1978","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB46|cit46","first-page":"109","article-title":"A comparative study of fluspirilene and fluphenazine decanoate in schizophrenic patients","volume":"2","author":"Magnus","year":"1979","journal-title":"Journal of Pharmacotherapy"},{"key":"10.1002\/14651858.CD000307-BIB47|cit47","first-page":"1758","article-title":"Fluspirilene and fluphenazine decanoate for schizophrenic patients. Controlled study","volume":"122","author":"Magnus","year":"1980","journal-title":"Munchener Medizinische Wochenschriftenschrift"},{"key":"10.1002\/14651858.CD000307-BIB48|cit48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0447.1974.tb08047.x","article-title":"A Multicentre Trial of Flusperilene and Fluphenazine Enanthate in Chronic Schizophrenic syndromes","volume":"249","author":"Malm","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000307-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archpsyc.1983.01790220015002","article-title":"Costs and benefits of two doses of fluphenazine","volume":"41","author":"Marder","year":"1984","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB50|cit50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.1987.01800180028005","article-title":"Low and conventional dose maintenance therapy with fluphenazine decanoate","volume":"44","author":"Marder","year":"1987","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archpsyc.1976.01770120039003","article-title":"Very high dose fluphenazine decanoate","volume":"33","author":"McClelland","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB52|cit52","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.137.6.510","article-title":"Intermittant pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"137","author":"McCreadie","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB53|cit53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.140.3.280","article-title":"Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"140","author":"McCreadie","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB54|cit54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.151.3.333","article-title":"Haloperidol decanoate versus fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients","volume":"151","author":"McKane","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB56|cit55","first-page":"67","article-title":"C, Silverstone T. Postive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromoperidol and fluphenazine decanoates","volume":"7","author":"McLaren","year":"1992","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB55|cit56","series-title":"Annual Meeting of the British Association for Psychopharmacology; 1990 July 15, Cambridge, England","article-title":"A comparative trial of bromperidol decanoate and fluphenazine decanoate in chronic","author":"McLaren","year":"1990"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB57|cit57","first-page":"195","article-title":"Double-blind placebo substitution: Withdrawal of fluphenazine decanoate in schizophrenic patients","volume":"43","author":"Odejide","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB58|cit58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0447.1979.tb00281.x","article-title":"A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate int he treatment of chronic schizophrenia","volume":"60","author":"Pinto","year":"1979","journal-title":"Acta Psychiatria Scandinavia"},{"key":"10.1002\/14651858.CD000307-BIB59|cit59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0447.1979.tb00281.x","article-title":"A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate int he treatment of chronic schizophrenia","volume":"60","author":"Pinto","year":"1979","journal-title":"Acta Psychiatria Scandinavia"},{"key":"10.1002\/14651858.CD000307-BIB60|cit60","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archpsyc.1978.01770310095007","article-title":"Long-acting oral vs injectable antipsychotic drugs in schizophrenics","volume":"35","author":"Quitkin","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB62|cit61","first-page":"40","article-title":"Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics II. Rating scale data","volume":"13","author":"Rifkin","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB61|cit62","first-page":"499","article-title":"The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics","volume":"14","author":"Rifkin","year":"1979","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB63|cit63","first-page":"15","article-title":"Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics - Rating scale data","volume":"34","author":"Rifkin","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB64|cit64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1977.01770130045004","article-title":"Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics - Relapse years after one year","volume":"34","author":"Rifkin","year":"1977","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB65|cit65","first-page":"1379","article-title":"Therapeutic evaluation of bromperidol decanoate in schizophrenia - a double-blind comparison vs. Fluphenazine decanoate","volume":"114","author":"Rossi","year":"1990","journal-title":"Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali"},{"key":"10.1002\/14651858.CD000307-BIB66|cit66","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/070674378202700714","article-title":"A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia","volume":"27","author":"Russell","year":"1982","journal-title":"Canadian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB67|cit67","first-page":"642","article-title":"A comparative controlled study of two long-acting phenothiazines: Pipothiazine palmitate and fluphenazine decanoate","volume":"23","author":"Schlosberg","year":"1978","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000307-BIB68|cit68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1019579","article-title":"Clinical blood chemistry values and long acting phenothiazines","volume":"14","author":"Schneider","year":"1981","journal-title":"Pharmacopsychitria"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB69|cit69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0041-1723921","article-title":"The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine","volume":"9","author":"Schooler","year":"1976","journal-title":"Pharmakopsychiatria"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB70|cit70","first-page":"44","article-title":"Depot fluphenazine in the prevention of relapse in schizophrenia: Evaluation of a Treatment Regimen","volume":"15","author":"Schooler","year":"1979","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB71|cit71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/ajp.136.2.217","article-title":"Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate","volume":"136","author":"Gelenberg","year":"1979","journal-title":"Amercian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB72|cit72","first-page":"483","article-title":"Discontinuation of oral and depot fluphenazine in schizophrenic patients ater one year of continuous medication: A controlled study","volume":"24","author":"Levine","year":"1980","journal-title":"Advanced Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB73|cit73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archpsyc.1982.04290020051010","article-title":"Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics","volume":"39","author":"Mandel","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB74|cit74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0041-1723921","article-title":"The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparison between oral and depot fluphenazine","volume":"9","author":"Schooler","year":"1976","journal-title":"Pharmakopsychiatria"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB76|cit75","first-page":"44","article-title":"Depot fluphenazine in the prevention of relapse in schizophrenia: Evaluation of a Treatment Regimen","volume":"15","author":"Schooler","year":"1979","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB75|cit76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archpsyc.1980.01780140018002","article-title":"Prevention of relapse in schizophrenia - An evaluation of fluphenazine decanoate","volume":"37","author":"Schooler","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB77|cit77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archpsyc.1997.01830170079011","article-title":"Relapse and rehospitalisation during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment","volume":"54","author":"Schooler","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB78|cit78","first-page":"177","article-title":"A comparison of fluphenazine decanoate and haloperidol decanoate in chronic schizophrenia","volume":"2","author":"Sharma","year":"1991","journal-title":"British Journal of Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB79|cit79","first-page":"141","article-title":"Double-blind study of domestic penfluridol and fluphenazine decanoate","volume":"16","author":"Shu","year":"1983","journal-title":"Chung Hua Shen Ching Ching Shen Ko Tsa Chih (Chinese Journal of Neurology and Psychiatry)"},{"key":"10.1002\/14651858.CD000307-BIB80|cit80","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1978.01770310099008","article-title":"Standard and long-acting depot neuroleptics in chronic schizophrenics","volume":"35","author":"Simon","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB81|cit81","first-page":"121","article-title":"A comparative study of prolonged action (depot) neuroleptics: pipotiazine palmitate versus fluphenazine enanthate in chronic schizophrenic patients","volume":"25","author":"Singh","year":"1979","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB82|cit82","first-page":"137","article-title":"A double-blind control study on the effect of pipotiazine palmitate and fluphenazine decanoate in the treatment of schizophrenia","volume":"26","author":"Song","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB83|cit83","first-page":"165","article-title":"A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients","volume":"73","author":"Praag","year":"1970","journal-title":"Psychiatria, Neurologia, Neurochirurgia"},{"issue":"7","key":"10.1002\/14651858.CD000307-BIB84|cit84","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1176\/ajp.130.7.801","article-title":"Fluphenazine enanthate and fluphenazine decanoate: A comparison of their duration of action and motor side effects","volume":"130","author":"Praag","year":"1973","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB85|cit85","first-page":"289","article-title":"A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients","volume":"3","author":"Walker","year":"1983","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD000307-BIB86|cit86","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-0447.1983.tb09718.x","article-title":"Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology","volume":"67","author":"Wistedt","year":"1983","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"Supp 1","key":"10.1002\/14651858.CD000307-BIB88|cit87","first-page":"15","article-title":"A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients","volume":"1","author":"Wistedt","year":"1986","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB87|cit88","first-page":"804","article-title":"A clinical double-blind comparison between haloperidol decanoate and fluphenazine decanoate","volume":"35","author":"Wistedt","year":"1984","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB89|cit89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000468309","article-title":"International Pharmacopsychiatry","volume":"12","author":"Woggon","year":"1977","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000307-BIB90|cit90","first-page":"72","article-title":"Fluphenazine in chronic schizophrenia","author":"Abuzzahab","year":"1976","journal-title":"Unidentified report"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB91|cit91","first-page":"26","article-title":"A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"12","author":"Abuzzahab","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB92|cit92","first-page":"71","article-title":"Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"13","author":"Abuzzahab","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB93|cit93","first-page":"547","article-title":"Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl","volume":"24","author":"Abuzzahab","year":"1980","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB94|cit94","series-title":"5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico","article-title":"A double-blind trial with long-acting neuroleptics","author":"Ahlfors","year":"1971"},{"key":"10.1002\/14651858.CD000307-BIB95|cit95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1973.tb07047.x","article-title":"Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine decanoate","volume":"241","author":"Ahlfors","year":"1973","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307-BIB96|cit96","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0278-5846(87)90022-4","article-title":"Fluphenazine decanoate in acute and maintenance therapy of schizophrenia","volume":"11","author":"Altamura","year":"1987","journal-title":"Progressive Neuro-Psychopharmacological and Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB97|cit97","first-page":"267","article-title":"Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazine decanoate, fluspirilene, penfluridol, perphenazine enanthate and pipothiazine palmitate","volume":"25","author":"Angst","year":"1975","journal-title":"Arzneimittel Forschung"},{"issue":"17","key":"10.1002\/14651858.CD000307-BIB98|cit98","first-page":"1015","article-title":"Experience with depot neuroleptics","volume":"not known","author":"Arato","year":"1979","journal-title":"Orvosi Hetilap"},{"key":"10.1002\/14651858.CD000307-BIB99|cit99","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0447.1974.tb09710.x","article-title":"A study of flupenthixol decanoate and pipothiazine undecylenate in schizophrenics","volume":"50","author":"Astrup","year":"1974","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB100|cit100","first-page":"116","article-title":"A comparison of the efficacy of fluphenazine decanoate and hydroxyprotepine decanoate in the treatment of schizophrenia (a double-blind crossover study). 1982;82:116-8","volume":"82","author":"Balon","year":"1982","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB101|cit101","first-page":"56","article-title":"A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients","volume":"29","author":"Bankier","year":"1968","journal-title":"Diseases of the Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB102|cit102","first-page":"49","article-title":"Efficacy and safety of fluphenthixol decanoate in chronic schizophrenia","volume":"17","author":"Bao","year":"1991","journal-title":"Chinese Journal of Nervous and Mental Disorders"},{"key":"10.1002\/14651858.CD000307-BIB103|cit103","first-page":"496","article-title":"A double blind study of fluphenazine enanthate","volume":"26","author":"Barsa","year":"1965","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB104|cit104","first-page":"531","article-title":"Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate","volume":"1","author":"Bastie","year":"1974","journal-title":"Annales Medico Psychologiques"},{"key":"10.1002\/14651858.CD000307-BIB105|cit105","first-page":"1803","article-title":"no English title given","volume":"not known","author":"Benassi","journal-title":"not known"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB106|cit106","first-page":"305","article-title":"No English title given","volume":"74","author":"Berliner","year":"1974","journal-title":"Acta Psychiatria Belgique"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000307-BIB107|cit107","first-page":"49","article-title":"Fluphenazine decanoate and haloperidol decanoate - 2 neuroleptics compared in nonacute psychiatric pathology. Long-term crossover trial. II. Tolerability and side effects","volume":"8","author":"Bilone","year":"1988","journal-title":"Neurologia Psichiatria Scienze Umane"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB108|cit108","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1017\/S0767399X0000095X","article-title":"Determinants for clinical activity of neuroleptic drugs: chemical substances, doses, assessment tools","volume":"2","author":"Boyer","year":"1987","journal-title":"Psychiatrie and Psychobiologie"},{"key":"10.1002\/14651858.CD000307-BIB109|cit109","series-title":"21st Congress of the Collegium Internationale Neuro-psychopharmacologicum; 1998 Jul 12-16; Glasgow, Scotland","article-title":"No difference between the effects of clozapine and fluphenazine on probabilistic reasoning in paranoid schizophrenia","author":"Brankovic","year":"1998"},{"key":"10.1002\/14651858.CD000307-BIB110|cit110","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1176\/ajp.144.12.1549","article-title":"Neuroleptic responsivity of negative and positive symptoms in schizophrenia","volume":"144","author":"Breier","year":"1987","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB111|cit111","first-page":"132","article-title":"A double-blind evaluation of sulpiride, a new antipsychotic compound","volume":"14","author":"Caranza","year":"1973","journal-title":"American Social Clinical Pharmacological Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB112|cit112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-9964(92)90127-Q","article-title":"Novel neuroleptic dosage reduction strategies","volume":"6","author":"Carpenter","year":"1992","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB113|cit113","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/ajp.156.3.412","article-title":"Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks","volume":"156","author":"Carpenter","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB114|cit114","series-title":"Psychiatry Today: Accomplishments and Promises. Proceedings of the 8th World Congress of Psychiatry; 1989 Oct 13-19; Athens, Greece","article-title":"Bromperidol decanoate vs fluphenazine decanoate in schizophrenia","author":"Casacchia","year":"1989"},{"key":"10.1002\/14651858.CD000307-BIB115|cit115","unstructured":"Castellini A Lorini M Flufenazina decanoato e aloperidolo decanoato: due neurolettici a confronto nella patologia psichiatrica non acuta studio crossover a lunga termine not known not known 33 48"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB116|cit116","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0010-440X(72)90055-7","article-title":"Work study in the assessment of the effects of phenothiazines in schizophrenia","volume":"13","author":"Chacon","year":"1972","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB117|cit117","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1973.tb04399.x","article-title":"Clinical and work performance variables in phenothiazine therapy of schizophrenia","volume":"49","author":"Chacon","year":"1973","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB118|cit118","first-page":"215","article-title":"Penfluridol versus oral fluphenazine in the maintenance treatment of chronic schizophrenics","volume":"21","author":"Charalampous","year":"1977","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB119|cit119","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/ajp.131.1.86","article-title":"Antiparkinsonian agents and depot phenothiazine","volume":"131","author":"Chein","year":"1974","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/ajp.120.10.1010","article-title":"Comparison of four regimens in newly admitted female schizophrenics","volume":"120","author":"Childers","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD000307-BIB121|cit121","first-page":"598","article-title":"Pimozide in the treatment of chronic schizophrenic patients","volume":"12","author":"Chouinard","year":"1970","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB122|cit122","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0010-440X(80)90090-5","article-title":"Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics","volume":"21","author":"Chowdhury","year":"1980","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB123|cit123","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archpsyc.1971.01750170020004","article-title":"Drug treatment in newly admitted schizophrenic patients","volume":"25","author":"Clark","year":"1971","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB124|cit124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004714-198512000-00004","article-title":"Plasma levels of neuroleptic in patients receiving depot fluphenazine","volume":"5","author":"Cohen","year":"1985","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB125|cit125","first-page":"369","article-title":"Differences in clinical effects of three phenothiazines in \"acute\" schizophrenia","volume":"446","author":"Cole","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000307-BIB126|cit126","first-page":"S24","article-title":"Side effects during long-term treatment with depot antipsychotic medication","volume":"14","author":"Cookson","year":"1991","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB127|cit127","first-page":"269","article-title":"Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice","volume":"23","author":"Coufal","year":"1981","journal-title":"Activa Nervosa Superior (Praha)"},{"issue":"8111","key":"10.1002\/14651858.CD000307-BIB128|cit128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(79)90749-9","article-title":"Unwanted effects of fluphenazine enanthate and decanoate (letter)","volume":"1","author":"Curry","year":"1979","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000307-BIB129|cit129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.146.5.464","article-title":"Long term depot maintenance of chronic schizophrenic out-patients: The seven year follow-up of the Medical Reseach Council fluphenazine\/placebo trial","volume":"146","author":"Curson","year":"1985","journal-title":"British Journal of Psychiatry"},{"issue":"6549","key":"10.1002\/14651858.CD000307-BIB130|cit130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.293.6549.726","article-title":"Does short term placebo treatment of chronic schizophrenia produce long term harm?","volume":"293","author":"Curson","year":"1986","journal-title":"British Medical Journal Clinical Research Edition"},{"issue":"6 September","key":"10.1002\/14651858.CD000307-BIB131|cit131","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.3.5670.564","article-title":"Severe depressive mood changes following slow-release intramuscular fluphenazine injection","volume":"3","author":"Alarcon","year":"1969","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB132|cit132","article-title":"Relative safety and efficacy of high and low dose administration of fluphenazine-hcl to psychotic patients","volume-title":"Psychopharmacology sexual disorders and drug abuse","author":"Buck","year":"1973"},{"key":"10.1002\/14651858.CD000307-BIB133|cit133","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0033-3182(75)71232-X","article-title":"Prevention of recidivism of schizophrenics treated with fluphenazine enanthate","volume":"16","author":"Guidice","year":"1976","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000307-BIB134|cit134","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0447.1978.tb06909.x","article-title":"High doses of fluphenazine enanthate in schizophrenia","volume":"57","author":"Dencker","year":"1978","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307-BIB135|cit135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/08039488109101727","article-title":"Pharmaco kinetics of fluphenazine depot in megadose: Comparison between the enanthate and the decanoate form","volume":"Not known","author":"Dencker","year":"1981","journal-title":"Nordic Psykiatria Tidsskria"},{"key":"10.1002\/14651858.CD000307-BIB136|cit136","first-page":"977","article-title":"Contribution to the infusion therapy with fluphenazine in schizophrenics with regard to the control of the neuroleptic threshold","volume":"16","author":"Dengler","year":"1969","journal-title":"Medizinische Welt"},{"key":"10.1002\/14651858.CD000307-BIB137|cit137","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0033-3182(71)71533-3","article-title":"Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients: An experimental evaluation","volume":"12","author":"DeWolfe","year":"1971","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000307-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1176\/ajp.133.11.1265","article-title":"Depression and the reintegration phase of acute schizophrenia","volume":"133","author":"Donlon","year":"1976","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB139|cit139","first-page":"119","article-title":"Pimozide versus fluphenazine in ambulatory schizophrenics: a 12-month comparison study","volume":"38","author":"Donlon","year":"1977","journal-title":"Diseases of the Nervous System"},{"issue":"11","key":"10.1002\/14651858.CD000307-BIB140|cit140","first-page":"800","article-title":"High vs standard dosage fluphenazine HCL in acute schizophrenia","volume":"39","author":"Donlon","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB141|cit141","first-page":"416","article-title":"Penfluridol vs fluphenazine decanaote: A double-blind clinical study in chronic and subchronic schizophrenia","volume":"43","author":"Doongaji","year":"1988","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000307-BIB142|cit142","series-title":"10th European College of Neuropsychopharmacology Congress; 1997 Sep 13-17; Vienna, Austria","article-title":"Olanzapine versus fluphenazine - six weeks' treatment of acute schizophrenia","author":"Dossenbach","year":"1997"},{"issue":"1,2","key":"10.1002\/14651858.CD000307-BIB143|cit143","first-page":"203","article-title":"Olanzapine versus fluphenazine - 6 weeks treatment of anxiety symptoms during acute schizophrenia","volume":"29","author":"Dossenbach M\/\/Jakovljevic M\/\/Folnegovic F\/\/Uglesic B\/\/Dodig G\/\/Friedel P\/\/Hotujac","year":"1998","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB144|cit144","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2466\/pms.1963.17.2.511","article-title":"Effect of phenothiazines on the thinking of acute schizophrenics","volume":"17","author":"Downing","year":"1963","journal-title":"Perceptual and Motor Skills"},{"key":"10.1002\/14651858.CD000307-BIB145|cit145","series-title":"11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany","first-page":"287","article-title":"'Seroquel' In partially responsive schizophrenics","author":"Emsley","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB146|cit146","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF01537988","article-title":"A double blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children","volume":"3","author":"Engelhardt","year":"1973","journal-title":"Journal of Autism and Childhood Schizophrenia"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB147|cit147","first-page":"167","article-title":"The depot compounds moditen (fluphenazine) and IMAP (flusipirilene) in clinical practice","volume":"16","author":"Faltus","year":"1974","journal-title":"Active Nervosa Superior"},{"key":"10.1002\/14651858.CD000307-BIB148|cit148","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1176\/ajp.126.11.1670","article-title":"Comparison of haloperidol and fluphenazine in disturbed children","volume":"126","author":"Faretra","year":"1970","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB149|cit149","series-title":"153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, USA","article-title":"Predictive value of early anti anxiety effect on the acute antipsychotic outcome: a comparison of fluphenazine and olanzapine","author":"Ferenc","year":"2000"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB150|cit150","first-page":"6","article-title":"Oxyprothepin decanoate in maintenance therapy of schizophrenia - a double-blind, standardized controlled study","volume":"81","author":"Filip","year":"1985","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB151|cit151","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000468199","article-title":"The problem of post-psychotic schizophrenic depressions and pharmacological induction","volume":"10","author":"Floru","year":"1975","journal-title":"International Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD000307-BIB152|cit152","first-page":"7","article-title":"Clinical profiles of the effects, indications, preferential therapeutic effect and contraindication of three depot neuroleptics compared in a multicentre trial","volume":"25","author":"Gianelli","year":"1994","journal-title":"Revista di Psychiatria"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB153|cit153","first-page":"7","article-title":"Clinical profiles of the effects, indications, preferential therapeutic effect and contraindication of three depot neuroleptics compared in a multicentre trial","volume":"25","author":"Giannelli","year":"1990","journal-title":"Rivista di Psichiatria"},{"key":"10.1002\/14651858.CD000307-BIB154|cit154","first-page":"551","article-title":"The effects of fluphenazine decanoate injection and chlorpromazine on symptom severity and learning in outpatient schizophrenics","volume":"29","author":"Gillis","year":"1981","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB155|cit155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00004714-198802000-00010","article-title":"Persistance of fluphenazine in plasma after decanoate withdrawal","volume":"8","author":"Gitlin","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB156|cit156","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archpsyc.1967.01730190109015","article-title":"Prediction of improvement in schizophrenia under four phenothiazines","volume":"16","author":"Goldberg","year":"1967","journal-title":"Archives General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB157|cit157","first-page":"153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB158|cit158","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0033-3182(70)71650-2","article-title":"A clinical evaluation of prolixin enanthate","volume":"11","author":"Goldberg Harold","year":"1970","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB159|cit159","first-page":"116","article-title":"The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics","volume":"17","author":"Goldberg","year":"1981","journal-title":"Psychopharmacology Bulletin"},{"issue":"Supp","key":"10.1002\/14651858.CD000307-BIB160|cit160","first-page":"32","article-title":"Experience of psychiatric management of schizophrenia with fluphenazine decanoate","volume":"31","author":"Grosser","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307-BIB161|cit161","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1192\/bjp.114.512.837","article-title":"A controlled trial of fluphenazine enanthate in hospitalized chronic schizophrennics","volume":"114","author":"Haider","year":"1968","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB162|cit162","first-page":"405","article-title":"A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics","volume":"29","author":"Hall","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307-BIB163|cit163","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00496067","article-title":"A comparative trial of the decanoates of flupenthixol and fluphenazine","volume":"64","author":"Hamilton","year":"1979","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB164|cit164","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenothiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000307-BIB165|cit165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2125.1976.tb03713.x","article-title":"Work performance versus clinical assessment in the evaluation of phenothiazine therapy","volume":"3","author":"Harper","year":"1976","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000307-BIB166|cit166","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0447.1975.tb00217.x","article-title":"A comparative trial of fluphenazine decanoate and flupenthixol decanoate","volume":"51","author":"Haslam","year":"1975","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB167|cit167","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-3956(70)90008-7","article-title":"Effect of phenothiazines on reaction time in schizophrenics","volume":"7","author":"Held","year":"1970","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD000307-BIB168|cit168","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Outpatients maintenance of chronic schizophrenic pateints with long-acting fluphenazine: double-blind placebo trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB169|cit169","first-page":"715","article-title":"Outpatient maintenance of chronic schizophrenics with long acting fluphenazine","volume":"17","author":"Hirsch","year":"1873","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB170|cit170","first-page":"792","article-title":"The social value of fluphenazine decanoate","volume":"76","author":"Stevens","year":"1976","journal-title":"Acta Psychitria Belgique"},{"key":"10.1002\/14651858.CD000307-BIB171|cit171","first-page":"371","article-title":"Maintenance therapy in out-patient schizophrenics: a report of a double-blind trial comparison of fluphenazine decanoate and flupenthixol decanoate","volume":"133","author":"Hirsch","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB172|cit172","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/S0007125000295986","article-title":"The dysphoric syndrome in schizophrenia and its implications for relapse","volume":"155","author":"Hirsch","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB173|cit173","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.1995.03950130029004","article-title":"Pharmacotherapy of impaired affect in recovering schizophrenic patients","volume":"52","author":"Hogarty","year":"1995","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB174|cit174","first-page":"173","article-title":"Assessment and significance of changes in laboratory values with haloperidol and fluphenazine hydrochloride therapy","volume":"2","author":"Holden","year":"1970","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB175|cit175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB176|cit176","first-page":"807","article-title":"One year study of fluphenazine enanthate","volume":"28","author":"Hsu","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307-BIB177|cit177","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1176\/ajp.151.12.1753","article-title":"A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrneic patients","volume":"151","author":"Inderbitzin","year":"1994","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB178|cit178","first-page":"33","article-title":"Penfluridol in the maintenance therapy of schizophrenia","volume":"21","author":"Ionescu","year":"1983","journal-title":"Neurologie et Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB179|cit179","first-page":"375","article-title":"A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients","volume":"39","author":"Iqbal","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000307-BIB180|cit180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0006-3223(86)90129-0","article-title":"L-5-Hydroxytryptophan-induced delirium","volume":"21","author":"Irwin","year":"1986","journal-title":"Biological Psychiatry"},{"issue":"5-9","key":"10.1002\/14651858.CD000307-BIB181|cit181","first-page":"37","article-title":"Fluphenazine hydrochloride, enanthate, and decanoate in the management of chronic psychosis","volume":"31","author":"Itil","year":"1970","journal-title":"Diseases of the Nervous System"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB182|cit182","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0033-3182(70)71607-1","article-title":"Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride","volume":"11","author":"Itil","year":"1970","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB183|cit183","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1600-0447.1971.tb03701.x","article-title":"Clinical and quantitative EEG changes at different dosage levels of fluphenazine treatment","volume":"47","author":"Itil","year":"1971","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB184|cit184","first-page":"689","article-title":"Pipothiazine palmitate, A long-acting neuroleptic: Clinical and computerized EEG effects","volume":"24","author":"Itil","year":"1978","journal-title":"Current Therapeutic Research"},{"issue":"1-2","key":"10.1002\/14651858.CD000307-BIB185|cit185","first-page":"3","article-title":"Olanzapine versus fluphenazine in the acute (six-week) treatment of schizophrenia","volume":"11","author":"Jakovljevic","year":"1999","journal-title":"Psychiatria Danubina"},{"issue":"580","key":"10.1002\/14651858.CD000307-BIB186|cit186","first-page":"53","article-title":"Penfluridol: a double blind trial in chronic schizophrenia","volume":"85","author":"James","year":"1977","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB187|cit187","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0447.1975.tb11092.x","article-title":"A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia","volume":"51","author":"Johnson","year":"1975","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB188|cit188","first-page":"160","article-title":"Maintenance therapy with fluphenazine decanoate and oxyprothepine decanoate in schizophrenic patients - a DOUBLE blind cross-over comparative study","volume":"22","author":"Kabes","year":"1980","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB189|cit189","first-page":"16","article-title":"Clinical trial of oxyprothepin decanoate","volume":"76","author":"Kabes","year":"1980","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB190|cit190","first-page":"241","article-title":"Oxyprothepine decanoate in the maintenance treatment of schizophrenia: multiclinical controlled comparison with fluphenazine decanoate","volume":"23","author":"Kabes","year":"1981","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000307-BIB191|cit191","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0165-1781(79)90016-7","article-title":"Low dose fluphenazine decanoate in maintenance treatment of schizophrenia","volume":"1","author":"Kane","year":"1979","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000307-BIB192|cit192","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.1982.04290010048009","article-title":"Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia","volume":"39","author":"Kane","year":"1982","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB193|cit193","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/9.4.528","article-title":"Low dose medication in the treatment of schizophrenia","volume":"9","author":"Kane","year":"1983","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB194|cit194","unstructured":"Kelly D Conley RR Sexual side effects of quetiapine and risperidone compared with fluphenazine Stanley Foundation Research Awards - 1999 Research Award Recipients (http:\/\/www.stanleyresearch.org\/ accessed February 2001) 1999 98271218"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB195|cit195","first-page":"69","article-title":"Pimozide compared with fluphenazine in schizophrenia","volume":"25","author":"Kenway","year":"1971","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD000307-BIB196|cit196","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archpsyc.1968.01740040093012","article-title":"Long acting phenothiazine (fluphenazine decanoate) treatment of psychosis","volume":"18","author":"Keskiner","year":"1968","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB197|cit197","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0033-3182(68)71862-4","article-title":"Maintenance treatment of schizophrenic outpatients with a depot phenothiazine","volume":"9","author":"Keskiner","year":"1968","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB198|cit198","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/schbul\/5.1.118","article-title":"Therapists rating of achievement of objectives in psychotherapy with acute schizophrenics","volume":"5","author":"King CE Goldstein","year":"1979","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB199|cit199","first-page":"309","article-title":"Treatment of neuroleptic-resistant schizophrenic relapse","volume":"29","author":"Kinon","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB200|cit200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1176\/ajp.119.8.779","article-title":"A new method of drug therapy","volume":"119","author":"Kinross-Wright","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB201|cit201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.135.6.515","article-title":"Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients","volume":"135","author":"Knights","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB202|cit202","first-page":"371","article-title":"An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia","volume":"5","author":"Kong","year":"1989","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD000307-BIB203|cit203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/070674379403900405","article-title":"Fluphenazine treatment of DSM-III-R Male Schizophrenic Patients Among the Xhosa","volume":"39","author":"Landmark","year":"1994","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB204|cit204","first-page":"181","article-title":"Pimozide and the social behavior of schizophrenics","volume":"18","author":"Lapierre","year":"1975","journal-title":"Current Therapeutic Research"},{"issue":"1-2","key":"10.1002\/14651858.CD000307-BIB205|cit205","first-page":"8","article-title":"A controlled pimozide, fluphenazine and group psychotherapy study of chronic schizophrenics","volume":"1","author":"Lapierre","year":"1976","journal-title":"Psychiatric Journal of the University of Ottawa"},{"key":"10.1002\/14651858.CD000307-BIB206|cit206","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1176\/ajp.135.8.956","article-title":"A controlled study of penfluridol in the treatment of chronic schizophrenia","volume":"135","author":"Lapierre","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB207|cit207","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000407841","article-title":"AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics","volume":"2","author":"Lapierre","year":"1983","journal-title":"Modern Problems of Pharmacopsychiatry"},{"issue":"12","key":"10.1002\/14651858.CD000307-BIB208|cit208","first-page":"698","article-title":"Drug treatment of schizophrenic patients. A comparitive evaluation of chlorpromazine, chloprothixene, fluphenazine, reserpine, thioridazine and triflupromazine","volume":"23","author":"Lasky","year":"1962","journal-title":"Diseases of the Nervous System"},{"issue":"12","key":"10.1002\/14651858.CD000307-BIB209|cit209","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.3.5775.599","article-title":"Trial of maintenance therapy in schizophrenia","volume":"11","author":"Leff","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB210|cit210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1192\/bjp.123.6.659","article-title":"Life events and maintenance therapy in schizophrenic therapy","volume":"123","author":"Leff","year":"1973","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB211|cit211","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.152.5.765","article-title":"Fluphenazine plasma levels, dosage, efficacy, and side effects","volume":"152","author":"Levinson","year":"1995","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000307-BIB212|cit212","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.1990.01810200069010","article-title":"Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment","volume":"47","author":"Levinson","year":"1990","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB213|cit213","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1192\/bjp.160.3.365","article-title":"Timing of acute clinical response to fluphenazine","volume":"160","author":"Levinson","year":"1992","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB214|cit214","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-9964(94)90068-X","article-title":"Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia","volume":"12","author":"Litman","year":"1994","journal-title":"Schizophrenia research"},{"issue":"7","key":"10.1002\/14651858.CD000307-BIB215|cit215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/1099-1077(200010)15:7<513::AID-HUP213>3.0.CO;2-Y","article-title":"A preliminary study of the comparative effects of olanzapine and fluphenazine on cognition in schizophrenic patients","volume":"15","author":"Ljubin","year":"2000","journal-title":"Human Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB216|cit216","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00178510","article-title":"Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate","volume":"88","author":"Marder","year":"1986","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB217|cit217","first-page":"479","article-title":"Plasma levels of parent drug and metabolites in patients recieving oral and depot fluphenazine","volume":"25","author":"Marder","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB218|cit218","first-page":"256","article-title":"Fluphenazine plasma levels and clinical response","volume":"26","author":"Marder","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB219|cit219","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1192\/bjp.158.5.658","article-title":"Plasma levels of fluphenazine in patients receiving fluphenazine decanoate","volume":"158","author":"Marder","year":"1991","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB220|cit220","first-page":"79","article-title":"Early prediction of relapse in schizophrenia: An application of receiver operating characteristic (ROC) methods","volume":"27","author":"Marder","year":"1991","journal-title":"Psychopharmalogical Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB221|cit221","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.153.12.1585","article-title":"Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia","volume":"153","author":"Marder","year":"1996","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB222|cit222","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(00)90767-9","article-title":"Predictive value of early anti anxiety effect on the acute antipsychotic outcome: a comparison of fluphenazine and olanzapine","volume":"41","author":"Martenyi","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB223|cit223","first-page":"705","article-title":"Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)","volume":"2","author":"Martin","year":"1972","journal-title":"Annales Medico Psychologiques"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB224|cit224","first-page":"445","article-title":"Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives","volume":"19","author":"Mattes Jeffrey","year":"1984","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB225|cit225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/S0007125000116691","article-title":"Weekly pimozide versus fluphenazine decanoate in schizophrenic out and day patients","volume":"143","author":"McCreadie","year":"1983","journal-title":"British Journal of PSychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000307-BIB226|cit226","first-page":"13","article-title":"Depot neuroleptics as maintenance therapy in chronic schizophrenic in-patients","volume":"1","author":"McCreadie","year":"1986","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB227|cit227","first-page":"155","article-title":"Haloperidol decanoate (a new depot neuroleptic drug): double-blind study versus fluphenazine decanoate in schizophreniform disorders and chronic schizophrenia. ed. Cazullo C","volume-title":"In: Schizophrenia: an intergrative view","author":"Meco","year":"1987"},{"issue":"1,2","key":"10.1002\/14651858.CD000307-BIB228|cit228","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0920-9964(97)88682-3","article-title":"Olanzapine compared to fluphenazine in the treatment of schizophrenia","volume":"29","author":"Mimica","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000307-BIB229|cit229","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1192\/bjp.117.541.683","article-title":"A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia","volume":"117","author":"Morris","year":"1970","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB230|cit230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in acute schizophrenia","volume":"10","year":"1964","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB231|cit231","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000468334","article-title":"Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial","volume":"13","author":"Nestoros","year":"1978","journal-title":"International Pharmacopsychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000307-BIB232|cit232","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archpsyc.1993.01820200046005","article-title":"Effects of clozapine and fluphenazine treatment on responses to m chlorophenylpiperazine infusions in schizophrenia","volume":"50","author":"Owen","year":"1993","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB233|cit233","first-page":"29","article-title":"Flupentixol decanoate versus other neuroleptics in chronic schizophrenia","volume":"35","author":"Palma Wenzel","year":"1997","journal-title":"Revista Chilena de Neuropsiquiatria"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB234|cit234","first-page":"312","article-title":"A double blind, controlled, multicenter trial of low dose amisulpride (Solian(R) 50) versus low dose fluphenazine in the treatment of negative symptoms in chronic schizophrenia","volume":"3","author":"Pichot","year":"1988","journal-title":"Annales de Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD000307-BIB235|cit235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0767399X00000912","article-title":"Profiles of the pharmacologic response of positive and negative symptoms in schizophrenia","volume":"2","author":"Pickar","year":"1987","journal-title":"Psychiatrie and Psychobiologie"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB236|cit236","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archpsyc.1992.01820050009001","article-title":"Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine","volume":"49","author":"Pickar","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB237|cit237","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1994.03950020083008","article-title":"Clinical response to clozapine in patients with schizophrenia","volume":"51","author":"Pickar","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB238|cit238","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1176\/ajp.121.1.73","article-title":"Clinical trial of fluphenazine enanthate- A long-acting injectable tranquilizer","volume":"121","author":"Pollack","year":"1964","journal-title":"American Jornal of Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB239|cit239","first-page":"204","article-title":"Psychometric performance of clozapine and fluphenazine treated schizophrenics","volume":"28","author":"Preussler","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000307-BIB240|cit240","first-page":"207","article-title":"Psychometric performance of chronic schizophrenics treated with a typical neuroleptic (fluphenazine) or an atypical neuroleptic drug (clozapine) - a double-blind controlled clinical trial","volume":"30","author":"Preussler","year":"1997","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1002\/14651858.CD000307-BIB241|cit241","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archpsyc.1975.01760280074007","article-title":"Very high dosage vs standard dosage fluphenazine in schizophrenia. A double-blind study of nonchronic treatment-refractory patients","volume":"32","author":"Quitkin","year":"1975","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB242|cit242","first-page":"27","article-title":"A one year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple episode schizophrenics","volume":"12","author":"Quitkin","year":"1977","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB243|cit243","first-page":"33","article-title":"A controlled study of fluphenazine enanthate in chronic schizophrenic patients","volume":"25","author":"Ravaris","year":"1965","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307-BIB244|cit244","first-page":"248","article-title":"Further studies with fluphenazine enanthate: II. Relapse rate in patients deprived of medication","volume":"124","author":"Ravaris","year":"1967","journal-title":"Americal Journal of Psychology"},{"key":"10.1002\/14651858.CD000307-BIB245|cit245","first-page":"24","article-title":"Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics","volume":"12","author":"Rifkin","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB246|cit246","first-page":"216","article-title":"Haloperidol decanoate as a replacement therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses","volume":"82","author":"Roose","year":"1982","journal-title":"Acta Psychiatria Belgique"},{"key":"10.1002\/14651858.CD000307-BIB247|cit247","first-page":"212","article-title":"Neuropsychological test performance of chronic schizophrenics treated with clozapine or fluphenazine - a double-blind, controlled clinical trial","volume":"30","author":"Rossger","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000307-BIB248|cit248","series-title":"Breaking down the barrires, 4th International Conference, Vancouver, B.C., Canada October 6-9, 1996","article-title":"The value of depot neuroleptic injections in the treatment of chronic schizophrenia. Conference: schizophrenia 1996: Breaking down the barriers, 4th International Conference, Vancouver, B.C","author":"Saxena","year":"1996"},{"key":"10.1002\/14651858.CD000307-BIB249|cit249","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1016\/S0924-977X(99)80357-5","article-title":"Impact of olanzapine versus fluphenazine on patient's drug acceptance during acute treatment of schizophrenia","volume":"9","author":"Schausberger","year":"1999","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB250|cit250","series-title":"11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany","article-title":"Impact of olanzapine vs. Fluphenazine on patient's drug acceptance during acute treatment of schizophrenia","author":"Schausberger","year":"1999"},{"issue":"16","key":"10.1002\/14651858.CD000307-BIB251|cit251","first-page":"707","article-title":"Depot neuroleptics in the treatment of schizophrenia","volume":"115","author":"Schipper","year":"1971","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB252|cit252","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archpsyc.1971.01750140042008","article-title":"Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines","volume":"25","author":"Schooler","year":"1971","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB253|cit253","first-page":"29","article-title":"Dosage and side effect comparisons between oral and depot fluphenazine","volume":"13","author":"Schooler","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB254|cit254","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/978-3-663-01928-2_4","article-title":"On minus symptoms in chronic schizophrenic patients and their reactions to neuroleptic drugs","volume-title":"Schizophrene Erkrankungen. Therapie Therapieresistenz eine Standortbestimmung","author":"Schubert","year":"1988"},{"key":"10.1002\/14651858.CD000307-BIB255|cit255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0447.1970.tb02069.x","article-title":"A controlled comparison of the treatment of schizophrenic patients when treated according to the neurologic threshold or by clinical judgment","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"11","key":"10.1002\/14651858.CD000307-BIB256|cit256","first-page":"470","article-title":"A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse","volume":"55","author":"Steingard","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB257|cit257","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0033291700048480","article-title":"Role of fluphenazine decanaote in lessening the burden of chronic schizophrenics on the community","volume":"3","author":"Stevens","year":"1973","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000307-BIB258|cit258","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-2007-1017319","article-title":"A comparative trial of CIS(Z)-clopenthixol decanoate and fluphenazine decanoate","volume":"18","author":"Tegeler","year":"1985","journal-title":"Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD000307-BIB259|cit259","first-page":"191","article-title":"None given","volume":"14","author":"Tretreault","year":"1969","journal-title":"Canadian Psychiatric Associative Journal"},{"key":"10.1002\/14651858.CD000307-BIB260|cit260","doi-asserted-by":"crossref","first-page":"109S","DOI":"10.1016\/S0006-3223(98)90811-3","article-title":"Olanzapine versus fluphenazine: treatment of acute schizophrenic symptomatology and anxiety","volume":"43","author":"Tran","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB261|cit261","series-title":"151st Annual Meeting of the American Psychiatric Association; 1998 May 30-Jun 4; Toronto, Canada","article-title":"Olanzapine versus fluphenazine in schizophrenia","author":"Tran","year":"1998"},{"key":"10.1002\/14651858.CD000307-BIB262|cit262","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.2042-7158.1966.tb07825.x","article-title":"A comparison of fluphenazine and chlorpromazine on critical flicker fusion frequency","volume":"18","author":"Turner","year":"1966","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD000307-BIB263|cit263","first-page":"99","article-title":"Neurophysiological dynamics in the treatment of endogenous depression using reflexotherapy","volume":"90","author":"Ushakov","year":"1990","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"issue":"Suppl","key":"10.1002\/14651858.CD000307-BIB264|cit264","first-page":"12","article-title":"Low-dose treatment strategies","volume":"47","author":"Putten","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB265|cit265","first-page":"91","article-title":"Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients","volume":"27","author":"Putten","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB266|cit266","first-page":"260","article-title":"Generic substitution: comparing the clinical efficacy of a generic substitute for fluphenazine decanoate with the original product","volume":"88","author":"Verster","year":"1998","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB267|cit267","first-page":"149","article-title":"A comparison of fluphenazine, triflupromazine, and phenobarbital in the treatment of chronic schizophrenic patients: a double-blind controlled study","volume":"23","author":"Vestre","year":"1962","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000307-BIB268|cit268","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00174677","article-title":"Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate","volume":"94","author":"Viala","year":"1988","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD000307-BIB269|cit269","first-page":"819","article-title":"A controlled study of fluspirilene in chronic schizophrenia","volume":"12","author":"Villeneuve","year":"1970","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB270|cit270","first-page":"248","article-title":"Long acting peroral fluphenazine and its dosage in psychoses","volume":"12","author":"Vinar","year":"1970","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000307-BIB271|cit271","first-page":"269","article-title":"Stabilization and depot neuroleptic dosages","volume":"29","author":"Weiden","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB272|cit272","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF02244140","article-title":"Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia","volume":"101","author":"Wiles","year":"1990","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD000307-BIB273|cit273","first-page":"377","article-title":"A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia","volume":"27","author":"Winter","year":"1973","journal-title":"The British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD000307-BIB275|cit274","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1981.tb00761.x","article-title":"A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients","volume":"64","author":"Wistedt","year":"1981","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307-BIB274|cit275","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00433729","article-title":"A depot withdrawal study. Palsma concentration of fluphenazine and flupenthixol and relapse frequency","volume":"78","author":"Wistedt","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB276|cit276","first-page":"369","article-title":"Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics","volume":"44","author":"Wistedt","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB277|cit277","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00427950","article-title":"A depot neuroleptic withdrawal study neurological effects","volume":"80","author":"Wistedt","year":"1983","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000307-BIB278|cit278","first-page":"243","article-title":"Maintenance treatment of schizophrenia with oxyprothepine decanoate: double-blind comparison with standard","volume":"23","author":"Zapletalek","year":"1981","journal-title":"Activis Nervosa Superior (Praha)"},{"key":"10.1002\/14651858.CD000307-BIB279|cit279","series-title":"VII meeting of the International College of Neuropsychopharmacology","article-title":"Recidivism with long acting fluphenazine","author":"Giudice","year":"1970"},{"key":"10.1002\/14651858.CD000307-BIB280|cit280","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08039486909132331","article-title":"Fluphenazine enanthate in long term treatment of psychoses","volume":"23","author":"Engstrand","year":"1969","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"issue":"1","key":"10.1002\/14651858.CD000307-BIB281|cit281","first-page":"19","article-title":"Flupentixol vs fluphenazine in schizophrenia patients: a randomized controlled trial","volume":"15","author":"Jue","year":"1996","journal-title":"New Drugs and Clinical Remedies"},{"issue":"2","key":"10.1002\/14651858.CD000307-BIB282|cit282","first-page":"159","article-title":"A multiclinical study of the effectiveness of meclopin in maintenance therapy of schizophrenic patients - A DOUBLE-blind crossover comparative study with flufenazine decanoate","volume":"30","author":"Kabes","year":"1984","journal-title":"Farmakoterapeuticke Zpravy"},{"key":"10.1002\/14651858.CD000307-BIB283|cit283","first-page":"XLVI","article-title":"Antipsychotic efficacy of clozapine vs fluphenazine in positive and negative schizophrenia syndrome","volume":"103","author":"Ravanic","year":"1996","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD000307-BIB284|cit284","doi-asserted-by":"crossref","unstructured":"Aaes-Jorgenson A Pharmacokinetics of oral and depot neuroleptics-Clinical relevance Symposium Espo, 1985 Feb 1","DOI":"10.1007\/978-1-4613-2363-1_112"},{"issue":"Issue 1","key":"10.1002\/14651858.CD000307-BIB285|cit285","article-title":"Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]","author":"Alderson","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD000307-BIB286|cit286","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Statistics Notes: Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB287|cit287","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"A comprehensive psychopathological rating scale","volume":"Supp 271","author":"Asberg","year":"1978","journal-title":"Acta Psychiatria Scandinavca"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB288|cit288","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2165\/00002018-199410060-00005","article-title":"Long term depot antipsychotics. A risk benefit assessment","volume":"10","author":"Barnes","year":"1994","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD000307-BIB289|cit289","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000307-BIB290|cit290","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD000307-BIB291|cit291","volume-title":"The neuropsychology of schizophrenia","author":"David","year":"1994"},{"issue":"1Suppl","key":"10.1002\/14651858.CD000307-BIB292|cit292","first-page":"2S","article-title":"The natural course of schizophrenia and effective maintenance drug therapy","volume":"6","author":"Davis","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"670","key":"10.1002\/14651858.CD000307-BIB293|cit293","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.3.5670.564","article-title":"Severe depressive mood changes following slow-release intramuscular fluphenazine injection","volume":"3","author":"Alarcon","year":"1969","journal-title":"British Medical Journal"},{"issue":"supp 279","key":"10.1002\/14651858.CD000307-BIB294|cit294","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0447.1980.tb07084.x","article-title":"Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study","volume":"61","author":"Dencker","year":"1980","journal-title":"Acta Psychiatria Scandinavica"},{"key":"10.1002\/14651858.CD000307-BIB295|cit295","unstructured":"Derogatis LR SCL-90-R: Administration, procedures and scoring manual, for the revised version Clinical Psychometrics Reasearch Unit , John Hopkins University, Baltimore 1977"},{"issue":"6","key":"10.1002\/14651858.CD000307-BIB296|cit296","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000307-BIB297|cit297","unstructured":"Department of Health Burdens of Disease: a Discussion Document Department of Health. NHS Executive 1996"},{"key":"10.1002\/14651858.CD000307-BIB298|cit298","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000307-BIB299|cit299","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research","volume":"26","author":"Feighner","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB300|cit300","doi-asserted-by":"crossref","first-page":"876-83 876-83","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000307-BIB301|cit301","volume-title":"Clinincal Global Impression (CGI). In: Early clinical drug evaluation (ECDUE) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000307-BIB302|cit302","volume-title":"ECDEU Assessment manual for psychopharmacology. In: DHEW publication No (ADM)","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000307-BIB303|cit303","volume-title":"Compliance in health care","author":"Haynes","year":"1979"},{"key":"10.1002\/14651858.CD000307-BIB304|cit304","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000307-BIB305|cit305","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo controlled trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000307-BIB306|cit306","first-page":"799","article-title":"NOSIE-30: A treatment sensitive ward behavior scale","volume":"10","author":"Honigfeld","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000307-BIB307|cit307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0264180100000904","article-title":"Schizophrenia: manifestations, incidence and course indifferent cultures","volume":"20","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine Monograph Supplement"},{"issue":"suppl 5","key":"10.1002\/14651858.CD000307-BIB308|cit308","first-page":"30","article-title":"Depot neuroleptics: A comparison review of standard, intermediate and low-dose regimens","volume":"47","author":"Kane","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000307-BIB309|cit309","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia","volume":"8","author":"Kane","year":"1998","journal-title":"European Neuropschopharmacology"},{"key":"10.1002\/14651858.CD000307-BIB310|cit310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardised psychiatric assessment scale for rating psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"Supp9","key":"10.1002\/14651858.CD000307-BIB311|cit311","first-page":"18","article-title":"The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics","volume":"31","author":"Kurland","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000307-BIB312|cit312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1002\/14651858.CD000307-BIB313|cit313","first-page":"256","article-title":"Fluphenazine plasma levels and clinical response","volume":"26","author":"Marder","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000307-BIB314|cit314","unstructured":"Marshall (personel communication) (personel communication) 1998"},{"key":"10.1002\/14651858.CD000307-BIB315|cit315","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000307-BIB316|cit316","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000307-BIB317|cit317","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatria Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD000307-BIB318|cit318","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000307.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000307\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T07:59:08Z","timestamp":1704959948000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000307"}},"subtitle":[],"editor":[{"given":"Anthony","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2004,4,19]]},"references-count":318,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000307","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000307.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2004,4,19]]}}}